Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver G. Bosch

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Brain Research Bulletin|February 9, 2016
The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humansOliver G Bosch, Erich Seifritz
Praxis|February 1, 2018
Erich Seifritz, Oliver G. Bosch
International Journal of Bipolar Disorders|July 5, 2022
Psychedelics in the treatment of unipolar and bipolar depressionOliver G Bosch, Simon Halm, Erich Seifritz
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 9, 2012
Stress-related depression: neuroendocrine, genetic, and therapeutical aspectsOliver G Bosch, Erich Seifritz, Thomas C Wetter
Journal of Psychopharmacology (Oxford, England)|September 20, 2011
Reconsidering GHB: orphan drug or new model antidepressant?Oliver G Bosch, Boris B Quednow, Erich Seifritz, et al.
Journal of Affective Disorders|September 11, 2017
The potential impact of biochemical mediators on telomere attrition in major depressive disorder and implications for future study designs: A narrative reviewAndrei Manoliu, Oliver G Bosch, Janis Brakowski, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 2, 2014
A quantitiative LC-MS/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasmaMaría Salomé Gachet, Peter Rhyn, Oliver G Bosch, et al.
Pharmacopsychiatry|November 17, 2022
Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating PropertiesOliver G Bosch, Dario A Dornbierer, Francesco Bavato, et al.
Journal of Psychiatric Research|November 14, 2020
Aberrant striatal coupling with default mode and central executive network relates to self-reported avolition and anhedonia in schizophreniaJanis Brakowski, Andrei Manoliu, Philipp Homan, et al.
Biological Psychiatry|June 3, 2014
Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy VolunteersRainer Kraehenmann, Katrin H Preller, Milan Scheidegger, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Brain Research Bulletin|February 9, 2016
The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humansOliver G Bosch, Erich Seifritz
Praxis|February 1, 2018
Erich Seifritz, Oliver G. Bosch
International Journal of Bipolar Disorders|July 5, 2022
Psychedelics in the treatment of unipolar and bipolar depressionOliver G Bosch, Simon Halm, Erich Seifritz
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 9, 2012
Stress-related depression: neuroendocrine, genetic, and therapeutical aspectsOliver G Bosch, Erich Seifritz, Thomas C Wetter
Journal of Psychopharmacology (Oxford, England)|September 20, 2011
Reconsidering GHB: orphan drug or new model antidepressant?Oliver G Bosch, Boris B Quednow, Erich Seifritz, et al.
Journal of Affective Disorders|September 11, 2017
The potential impact of biochemical mediators on telomere attrition in major depressive disorder and implications for future study designs: A narrative reviewAndrei Manoliu, Oliver G Bosch, Janis Brakowski, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 2, 2014
A quantitiative LC-MS/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasmaMaría Salomé Gachet, Peter Rhyn, Oliver G Bosch, et al.
Pharmacopsychiatry|November 17, 2022
Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating PropertiesOliver G Bosch, Dario A Dornbierer, Francesco Bavato, et al.
Journal of Psychiatric Research|November 14, 2020
Aberrant striatal coupling with default mode and central executive network relates to self-reported avolition and anhedonia in schizophreniaJanis Brakowski, Andrei Manoliu, Philipp Homan, et al.
Biological Psychiatry|June 3, 2014
Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy VolunteersRainer Kraehenmann, Katrin H Preller, Milan Scheidegger, et al.
Pageof 4